Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Adma Biologics (ADMA) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Adma Biologics' Treasury Shares fell 7774.45% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 7774.45%. This contributed to the annual value of $12.5 million for FY2023, which is 755.81% down from last year.
  • Per Adma Biologics' latest filing, its Treasury Shares stood at $23.2 million for Q3 2025.
  • In the past 5 years, Adma Biologics' Treasury Shares ranged from a high of $13.5 million in Q4 2022 and a low of $686133.0 during Q2 2021
  • Its 5-year average for Treasury Shares is $5.2 million, with a median of $4.8 million in 2022.
  • In the last 5 years, Adma Biologics' Treasury Shares soared by 59117.55% in 2022 and then tumbled by 7774.45% in 2025.
  • Over the past 5 years, Adma Biologics' Treasury Shares (Quarter) stood at $4.5 million in 2021, then soared by 198.69% to $13.5 million in 2022, then decreased by 7.56% to $12.5 million in 2023, then plummeted by 52.24% to $6.0 million in 2024, then tumbled by 77.74% to $1.3 million in 2025.
  • Its Treasury Shares stands at $1.3 million for Q3 2025, versus $816237.0 for Q2 2025 and $5.9 million for Q1 2025.